{
    "code": "02016851",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02016851",
    "time": "2016-11-18 19:13:05",
    "許可證字號": "衛署藥輸字第016851號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/09\/19",
    "發證日期": "77\/09\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201685100",
    "中文品名": "&quot;愛爾康&quot;點必效眼藥膏",
    "英文品名": "TOBREX EYE OINTMENT",
    "適應症": "眼瞼炎、淚囊炎、麥粒腫、結膜炎、角膜炎。",
    "劑型": "461點眼膏劑",
    "包裝": "軟管裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "TOBRAMYCIN"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1304601100  瑞士商愛爾康大藥廠股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F410015000  ALCON CUSI S.A.",
        "製造廠廠址": "CAMIL FABRA, 58, 08320 EL MASNOU,BARCELONA,SPAIN",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30042000113 人用醫藥製劑，含胺基配醣體類抗生素者（含鏈黴素或其衍生物；其鹽類者除外）Medicaments, containing aminoglycosides (excluding streptomycins or their derivatives; salts thereof), for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812100900",
            "成分名稱": "TOBRAMYCIN",
            "含量描述": "(3000MCG)3",
            "含量": "",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI.tpe_TOBREX 3.5G TAIWAN_601460-104-10-01(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02016851&Seq=002&Type=9"
        },
        {
            "title": "020168510001___20121205.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02016851&Seq=001&Type=9"
        },
        {
            "title": "Label.en_TOBREX P.O. 3.5G G.E.V_2-50-640-104-10-01(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02016851&Seq=002&Type=8"
        },
        {
            "title": "Carton.tpe_TOBREX 3.5G_885431-104-10-01(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02016851&Seq=001&Type=8"
        }
    ]
}